Signature Announces Appointment of Dr. Dimitrios Kostopoulos to Its Advisory Board

Signature Resources Ltd. (TSXV:SGU, OTCQB:SGGTF) ("Signature" or the "Company") is pleased to announce that it has appoint Dr. Dimitrios Kostopoulos...

Report: Wind Energy in the US is now Cheaper Than Ever

The US Department of Energy's report shows that wind energy prices are at significant lows compared to 2009.

Ascent Solar Adds Dr. Miguel Contreras as Director of Process Engineering

Ascent Solar Technologies (OTCQB:ASTI) has added Dr. Miguel Contreras to its team effective July 10, 2017 as the director of...

Northern Vine Labs Expands Its Sales Team

Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE: ATT) (OTCQB: ATTBF) is pleased to announce the addition of Siobhan McCarthy...

Q BioMed Adds Experienced Industry Veterans to Strategic Resource Team

Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company is pleased to announce the appointment of Dr. Amy Ripka and...

NeuroVive Recruits Michele Tavecchio as Senior Scientist

NeuroVive Pharmaceutical, the mitochondrial medicine company, today announced that the company has recruited Michele Tavecchio, PhD, as senior scientist.

Corvus Pharmaceuticals Announces Preclinical and Preliminary Clinical Biomarker Data

Corvus Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies, today announced preclinical data...

Corvus Pharmaceuticals to Present Data on Lead Oral Checkpoint Inhibitor CPI-444 at Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology therapies, today announced...

MEMS & Sensors Industry Group Conference Asia Explores MEMS & Sensors in IoT of Today and Tomorrow

PITTSBURGH, PA–(Marketwired – Aug 8, 2016) – Recognizing the massive growth potential of MicroElectroMechanical systems (MEMS) and sensors in Internet...

Phase II Cervical Cancer Study with Advaxis’ Axalimogene Filolisbac Selected for Poster Discussion Session at the 2016 ASCO Annual Meeting

Poster Discussion Sessions highlight the most clinically applicable and novel posters PRINCETON, N.J., April 25, 2016 (GLOBE NEWSWIRE) —  Advaxis, Inc. (NASDAQ:ADXS),...